Report overview
Immunotherapy is a type of cancer treatment that helps your immune system fight cancer. The immune system helps your body fight infections and other diseases. It is made up of white blood cells and organs and tissues of the lymph system.
This report aims to provide a comprehensive presentation of the global market for Immunotherapy Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immunotherapy Drugs. This report contains market size and forecasts of Immunotherapy Drugs in global, including the following market information:
Global Immunotherapy Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Immunotherapy Drugs market was valued at US$ 199340 million in 2022 and is projected to reach US$ 392030 million by 2029, at a CAGR of 10.1% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North America is expected to account for largest share in the immunotherapy drugs market, by region in 2018. Asia-Pacific is expected to be the fastest-growing regional segment in the market. The high growth of this segment can primarily be attributed to the low cost of manufacturing and acceptable regulatory scenario in this region.
We surveyed the Immunotherapy Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Immunotherapy Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Immunotherapy Drugs Market Segment Percentages, by Type, 2022 (%)
Monoclonal Antibodies
Adult Vaccines
Checkpoint Inhibitors
Interferons Alpha & Beta
Interleukins
Others
Global Immunotherapy Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Immunotherapy Drugs Market Segment Percentages, by Application, 2022 (%)
Cancer
Autoimmune & Inflammatory Diseases
Infectious Diseases
Others
Global Immunotherapy Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Immunotherapy Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Immunotherapy Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Immunotherapy Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Merck
Novartis
Johnson & Johnson
Glaxosmithkline
Amgen
Abbvie
Astrazeneca
Bristol-Myers Squibb
ELI Lilly
Outline of Major Chapters:
Chapter 1: Introduces the definition of Immunotherapy Drugs, market overview.
Chapter 2: Global Immunotherapy Drugs market size in revenue.
Chapter 3: Detailed analysis of Immunotherapy Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Immunotherapy Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
